1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics, March 2016 (p20)

Biopharmaceutical Analysis & Statistics, March 2016 (p20)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

571-600 of about 800 reports

Purchase Reports From Reputable Market Research Publishers

Itero Biopharmaceuticals, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United Kingdom

Pronova BioPharma ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : United States, United Kingdom

KBI BioPharma, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
  • Countries : United States, United Kingdom

Oncolys Biopharma, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : United States

Viropro, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United States, United Kingdom

Intas Biopharmaceuticals Limited – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United Kingdom

Alios BioPharma, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United States, United Kingdom

Novozymes Biopharma UK, Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
  • Countries : United Kingdom

Therapure Biopharma, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : Denmark, Canada

Biotest Pharmaceuticals Corporation – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United States

Transposagen Biopharmaceuticals, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States

Synageva BioPharma Corp. (formerly AviGenics, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
  • Countries : United States

Aldagen, Inc. (formerly Stemco Biomedical, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United States

Scil Biomedicals GmbH – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : Germany

Biopharma Outsourcing Market: By Services (Clinical Trials, Drug Discovery, API Development, Contract Production & Packaging, Non-Clinical Services, Others); By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • March 2016
  • by Industry ARC

Biopharma outsourcing plays an important role in the growth of biopharmaceuticals market. The growth of this market is promising with rapidly expanding biosimilars base. With rising complexity of biologic ...

  • Industries : Biopharmaceutical

Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices (3rd Edition)

  • $ 900
  • Industry report
  • March 2016
  • by Industry Standard Research

A biosimilars boom is expected and both biopharma and contract manufacturers want to be positioned to capture a piece of the market. ISR’s Biosimilars Manufacturing: Key Considerations and Expected Outsourcing ...

  • Industries : Biopharmaceutical, Generic Drug

Sutro Biopharma, Inc. - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • February 2016
  • by Global Markets Direct

Sutro Biopharma, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Sutro Biopharma, Inc. - Product Pipeline Review - 2016’, provides an overview of the Sutro Biopharma, Inc.’s ...

  • Industries : Oncology, Research and Development, Biopharmaceutical, Therapy
  • Countries : United States

Erythropoietin Drugs Market: By Type(Epoetin-alfa, Beta, Omega, Delta & Darbepoetin-alfa), By Disease Cured(Oncology diseases, Kidney Disorders, Anemia, Neural Disease, Wound healing) & Geography-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • February 2016
  • by Industry ARC

Erythropoietin is a hormone released the human renal system (kidney) which increases the rate of production of red blood cells in response to falling levels of oxygen in the tissues and helps in the process ...

  • Industries : Biopharmaceutical, Pathology
  • Countries : World

Biosimilar Monoclonal Antibodies Market Forecast 2016-2026: Biosimilar Versions of Infliximab, Rituximab, Trastuzumab, Adalimumab, Bevacizumab and Abciximab

  • $ 2597
  • Industry report
  • February 2016
  • by Visiongain

Report Details You need a single report that pulls together best practice, forecasts, primary research and sales figures of biosimilar monoclonal antibodies all in one place. This report provides you with ...

  • Industries : Therapy
  • Countries : World

Bolder Biotechnology, Inc. - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • February 2016
  • by Global Markets Direct

Bolder Biotechnology, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Bolder Biotechnology, Inc. - Product Pipeline Review - 2016’, provides an overview of the Bolder Biotechnology, ...

  • Industries : Research and Development, Biological Therapy, Pathology
  • Countries : United States

Biosimilars and Follow-On Biologics’ Trends, R&D and Revenue Forecasts 2016-2026: Assess Prospects for MAbs, Fusion Proteins, Insulin, G-CSF, Erythropoietin, Interferons, Growth and Fertility Hormones

  • $ 6495
  • Industry report
  • February 2016
  • by Visiongain

Report Details Biosimilars – Discover Revenue Predictions from 2016, Benefiting Your Authority Do you want to find sales potentials of biosimilar drugs? If so, our new analysis gives you revenue forecasts ...

  • Industries : Biopharmaceutical, Generic Drug, Therapy, Biotechnology
  • Countries : Europe, World

Global Oncology Biosimilars Market 2016-2020

  • $ 2500
  • Industry report
  • February 2016
  • by Infiniti Research Limited

About Oncology Biosimilars Cancer represents a huge burden on healthcare systems worldwide due to the high cost of treatment therapeutics. The patent expiry of many cancer therapeutics enables the entry ...

  • Industries : Biopharmaceutical, Generic Drug
  • Countries : World

2016 Global Coagulation Factor Assay Testing Market: Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape--US, Europe, Japan (DataPack)

  • $ 3500
  • Industry report
  • February 2016
  • by Venture Planning Group

This DataPack contains tables from VPGMarketResearch.com new report, "2016 Global Coagulation Factor Assay Testing Market: Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive ...

  • Industries : Biopharmaceutical

Ipsen Biopharmaceuticals, Inc. - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • February 2016
  • by GlobalData

Ipsen Biopharmaceuticals, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains ...

  • Industries : Biopharmaceutical

US Biosimilars Market Opportunity & Clinical Pipeline Analysis

  • $ 2400
  • Industry report
  • February 2016
  • by Kuick Research

Pharmaceutical companies benefited from the revolution in biotechnology that hit US market in 1980’s. Some of the blockbuster biologics have been introduced in market helping pharmaceutical companies ...

  • Industries : Biopharmaceutical, Generic Drug
  • Countries : World

Global Biopharmaceutical Bioseparation Systems Industry

  • $ 4500
  • Industry report
  • February 2016
  • by Global Industry Analysts

This report analyzes the worldwide markets for Biopharmaceutical Bioseparation Systems in US$ Million by the following Product Segments: Chromatography Systems, and Other Bioseparation Systems. The report ...

  • Industries : Biopharmaceutical, Biotechnology, Diagnostics
  • Countries : United States, Europe, Japan, Asia

Biosimilars in Oncology: Update Bulletin [Feb 2016]

  • $ 1040
  • Industry report
  • February 2016
  • by Firstword Pharma

New KOL insights on the latest events that have the potential to shape the oncology biosimilars market. Topics covered include opinions about data from Sandoz’s PROTECT 1 and PROTECT 2 studies which ...

  • Industries : Biopharmaceutical, Generic Drug
  • Countries : Europe

Competitor Analysis: Anti-VEGF/R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis – a 2016 Update

  • $ 440
  • Industry report
  • February 2016
  • by La Merie Publishing

Competitor Analysis: Anti-VEGF/R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis – a 2016 UpdateThe Competitive Intelligence Report „Anti-VEGF/R Biosimilars and Biosuperiors ...

  • Industries : Oncology, Therapy

Ulcerative Colitis: Update Bulletin [Feb 2016]

  • $ 1040
  • Industry report
  • February 2016
  • by Firstword Pharma

Gain new KOL insights on the latest events happening in Ulcerative Colitis. Topics covered include opinions regarding Phase III data on Johnson & Johnson’s Stelara (ustekinumab) in Crohn’s disease ...

  • Industries : Therapy
  • Countries : Europe

Human Insulin Market - Drugs , Type , Brands , Delivery Devices , Applications - Forecasts to 2020

  • $ 5650
  • Industry report
  • January 2016
  • by MarketsandMarkets

The global human insulin market is poised to reach ~USD 39.13 billion by 2020 growing at a CAGR of 8.1% from 2015 to 2020. North America is expected to hold the largest share of the global human insulin ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World, Europe, United States, North America

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.